Coronavirus

Showing 1 - 25 of 191

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Coronavirus Trial (OVX033, Saline solution)

Not yet recruiting
  • Coronavirus
  • OVX033
  • Saline solution
  • (no location specified)
Nov 14, 2023

SARS-CoV-2 Infection, COVID-19, Coronavirus Trial in Marseille, Nîmes (eBAM Cov Testing)

Not yet recruiting
  • SARS-CoV-2 Infection
  • +2 more
  • eBAM Cov Testing
  • Marseille, France
  • +1 more
Oct 23, 2023

Coronavirus Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant novel

Not yet recruiting
  • Coronavirus
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Recombinant novel coronavirus protein vaccine (CHO cells)
  • (no location specified)
Sep 5, 2023

Cardiac Arrest, COVID-19, Coronavirus Trial in Canada, United States (Aerosol box)

Not yet recruiting
  • Cardiac Arrest
  • +2 more
  • Aerosol box
  • Los Angeles, California
  • +3 more
May 23, 2023

Coronavirus Trial in Wuhu (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant

Active, not recruiting
  • Coronavirus
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Recombinant novel coronavirus protein vaccine (CHO cells)
  • Wuhu, Anhui, China
    Wannan Medical College Yijishan Hospital
May 6, 2023

Severe Acute Respiratory Syndrome, Coronavirus, SARS-CoV-2 Trial in Belgium, Germany (CVnCoV Vaccine, Placebo)

Completed
  • Severe Acute Respiratory Syndrome
  • +3 more
  • CVnCoV Vaccine
  • Placebo
  • Ghent, Belgium
  • +3 more
Apr 29, 2022

Coronavirus Trial in Los Angeles (Change in knowledge, motivation, skills, resources)

Completed
  • Coronavirus
  • Change in knowledge, motivation, skills, resources
  • Los Angeles, California
    Charles R. Drew University of Medicine & Science
Jan 17, 2023

COVID19, Coronavirus, Acute Respiratory Illnesses Trial in Worldwide (Chloroquine or Hydroxychloroquine, Placebo)

Completed
  • COVID19
  • +2 more
  • Chloroquine or Hydroxychloroquine
  • Placebo
  • Abomey-Calavi, Benin
  • +24 more
Jan 10, 2023

Coronavirus, N95, Medical Mask Trial in Canada, Israel (Medical Mask, N95 respirator)

Completed
  • Coronavirus
  • +2 more
  • Medical Mask
  • N95 respirator
  • Calgary, Alberta, Canada
  • +14 more
Jan 11, 2023

SARS-CoV Infection, Coronavirus, Corona Virus Infection Trial in Copenhagen (An Oropharyngeal swab)

Recruiting
  • SARS-CoV Infection
  • +2 more
  • An Oropharyngeal swab
  • Copenhagen, Hillerød, Denmark
  • +1 more
Jan 10, 2023

Coronavirus Trial in Oxford (SARS-CoV-2 virus)

Recruiting
  • Coronavirus
  • SARS-CoV-2 virus
  • Oxford, Oxon, United Kingdom
  • +2 more
Jan 5, 2023

Dexamethasone and COVID-19 Inpatient Mortality

Completed
  • Coronavirus
  • Dexamethasone Oral
  • New York, New York
    Aetion, Inc.
Dec 7, 2022

Covid19, Coronavirus, Cancer Trial in United States (Aerobic Exercise Therapy)

Active, not recruiting
  • Covid19
  • +2 more
  • Aerobic Exercise Therapy
  • Basking Ridge, New Jersey
  • +6 more
Dec 6, 2022

Coronavirus, SARS-CoV-2 Infection, COVID-19 Trial in Imus, Makati City (PepGNP-COVID19 (One vaccination), Water for injection

Not yet recruiting
  • Coronavirus
  • +2 more
  • PepGNP-COVID19 (One vaccination)
  • +3 more
  • Imus, Cavite, Philippines
  • +1 more
Nov 30, 2022

Coronavirus, SARS-CoV-2 Infection, COVID-19 Trial in Lausanne (LD Vehicle-GNP, LD PepGNP-SARSCoV2, HD Vehicle-GNP)

Completed
  • Coronavirus
  • +2 more
  • LD Vehicle-GNP
  • +3 more
  • Lausanne, Vaud, Switzerland
    Center for Primary Care and Public Health (Unisante)
Nov 28, 2022

Coronavirus, Traditional Chinese Medicine Trial in Urumqi (Lianhua Qingke tablets)

Recruiting
  • Coronavirus
  • Traditional Chinese Medicine
  • Lianhua Qingke tablets
  • Urumqi, Xinjiang, China
    International Convention and Exhibition Center Shelter Hospital
Nov 14, 2022

Coronavirus, Traditional Chinese Medicine Trial in Urumqi (Lianhua Qingwen capsules)

Recruiting
  • Coronavirus
  • Traditional Chinese Medicine
  • Lianhua Qingwen capsules
  • Urumqi, Xinjiang, China
    International Convention and Exhibition Center Shelter Hospital
Nov 14, 2022

COVID-19, Coronavirus, SARS-CoV-2 Trial in United States (pathogen reduced SARS-CoV-2 convalescent plasma, Placebo)

Completed
  • COVID-19
  • +2 more
  • pathogen reduced SARS-CoV-2 convalescent plasma
  • Placebo
  • Little Rock, Arkansas
  • +25 more
Oct 6, 2022

Coronavirus Infection, Coronavirus, Infectious Disease Trial in Salt Lake City (Hydroxychloroquine, Placebo oral tablet)

Active, not recruiting
  • Coronavirus Infection
  • +2 more
  • Salt Lake City, Utah
    University of Utah
Nov 1, 2022

Coronavirus Trial in Oxford (ChAdOx1 nCov-19)

Completed
  • Coronavirus
  • ChAdOx1 nCov-19
  • Oxford, United Kingdom
    CCVTM, University of Oxford, Churchill Hospital
Oct 21, 2022

Coronavirus, Coronavirus Infection, Coronavirus as the Cause of Diseases Classified Elsewhere Trial in Los Angeles, Bryan,

Active, not recruiting
  • Coronavirus
  • +2 more
  • BCG Vaccine
  • Placebo Vaccine
  • Los Angeles, California
  • +5 more
Oct 18, 2022

Coronavirus, Child, Only Trial in Bartin (Training and activities)

Recruiting
  • Coronavirus
  • Child, Only
  • Training and activities
  • Bartın, Turkey
    Bartin Ertugrul Gazi Secondary School
Oct 6, 2022

Covid19, Coronavirus Trial in London (Corsodyl® Alcohol free -0.2 % Chlorhexidine digluconate, Colgate Peroxyl® -1.5% Hydrogen

Completed
  • Covid19
  • Coronavirus
  • Corsodyl® Alcohol free -0.2 % Chlorhexidine digluconate
  • +3 more
  • London, United Kingdom
  • +1 more
Sep 12, 2022

Vaccine Confidence and Uptake of Potential COVID-19 Vaccines

Recruiting
  • Coronavirus
  • Survey research
  • Greenville, North Carolina
    Carol Belk Building
Sep 8, 2022

Coronavirus, Inspiratory Muscle Training, Respiratory Infection Trial in João Pessoa (Active HD-tDCS, Control group)

Recruiting
  • Coronavirus
  • +3 more
  • Active HD-tDCS
  • Control group
  • João Pessoa, Paraíba, Brazil
    Suellen Andrade, pHD
Sep 1, 2022